Formulated for Whom? The Uncomfortable Science Behind Luxury Skincare and Skin Tone Disparity
The language of luxury skincare is, by design, universal. Words like radiance, luminosity, and clarity appear on packaging sold from Bergdorf Goodman to Neiman Marcus, promising a singular vision of glowing skin to every consumer who reaches for them. Yet beneath the gilded marketing lies a formulation history that has, for decades, quietly centered one complexion type while leaving others to navigate the consequences.
This is not a matter of intention. It is a matter of science—or more precisely, of which science has been prioritized, funded, and applied.
The Clinical Trial Problem
Before a luxury serum reaches a consumer's vanity, it undergoes efficacy testing. The benchmark for claims such as "visibly brightens in four weeks" or "reduces the appearance of hyperpigmentation" is clinical data—photographs, dermatologist assessments, and instrumental measurements conducted on real subjects.
The problem is who those subjects typically are.
A 2021 review published in the Journal of the American Academy of Dermatology found that the overwhelming majority of dermatological clinical trials—including those conducted for cosmetic product validation—enrolled participants with lighter skin tones, predominantly Fitzpatrick types I through III. Fitzpatrick types IV through VI, which encompass a broad range of medium to deep complexions, were significantly underrepresented. For a luxury market that actively courts consumers of all backgrounds, this is a foundational gap that no amount of diverse advertising can bridge.
What this means in practice is that a $280 brightening serum may have demonstrated measurable efficacy on a narrow demographic while its behavior on melanin-rich skin remains largely untested by the brand itself.
Melanin Is Not a Monolith
To understand why this matters physiologically, one must first appreciate that melanin—the pigment responsible for skin, hair, and eye color—is not a single entity. It exists in two primary forms: eumelanin, which produces brown and black tones, and pheomelanin, which produces red and yellow tones. Most individuals carry a combination of both, and the ratio, distribution, and density of these pigments vary enormously across individuals and across the same individual's body.
Melanocytes, the cells that produce melanin, are present in roughly equal numbers across skin tones. What differs is the size, distribution, and activity level of the melanosomes—the organelles within melanocytes that package and transfer pigment. In deeper complexions, melanosomes are larger, more numerous, and more evenly distributed throughout the skin layers. This structural difference has real implications for how active ingredients interact with the skin.
Retinoids, for instance, are among the most clinically validated ingredients in skincare. Yet studies have consistently shown that individuals with darker skin tones are more susceptible to retinoid-induced irritation and post-inflammatory hyperpigmentation—a cruel irony, given that hyperpigmentation is often the very concern driving the purchase. Similarly, certain chemical exfoliants, particularly those relying on glycolic acid at higher concentrations, can trigger melanin overproduction in deeper complexions when misapplied, worsening the unevenness they promise to correct.
The Radiance Equation Reimagined
The concept of "radiance" itself carries an embedded bias. The optical phenomenon that most luxury brands chase—a diffuse, light-scattering luminosity—manifests differently across skin tones. On lighter complexions, light reflects broadly and evenly, creating the dewy, lit-from-within effect that fills brand imagery. On medium to deep complexions, radiance expresses itself through clarity, dimension, and a rich luminosity that is distinct but equally compelling—and often requires entirely different ingredient strategies to achieve.
Light-diffusing ingredients such as mica, titanium dioxide, and certain silicones are calibrated, in most formulations, for the optical properties of lighter skin. The result is that products marketed as universally radiance-enhancing may appear ashy, chalky, or simply inert on deeper tones—not because the skin is unresponsive, but because the formula was never designed with its optical reality in mind.
Brands Beginning to Close the Gap
It would be incomplete to suggest that no progress is being made. A meaningful cohort of brands—some established, some emerging—is actively investing in more inclusive formulation science.
Fenty Skin, launched by Rihanna in 2020, built its foundational premise on skin inclusivity, conducting efficacy testing across a broader range of Fitzpatrick types and formulating its products with the full spectrum of complexions in mind. Topicals, a science-forward brand founded by Olamide Olowe, has centered clinical validation on skin of color from inception, addressing hyperpigmentation and barrier function with a specificity that the legacy luxury market has rarely offered.
Within the prestige tier, brands such as Dr. Barbara Sturm have expanded their product lines to include melanin-specific formulations, acknowledging that a one-size-fits-all approach to luxury skincare is neither scientifically sound nor commercially honest. These are meaningful steps, though the broader industry has yet to adopt inclusive testing as a universal standard.
A Framework for the Discerning Consumer
For consumers navigating this landscape, a more rigorous approach to product selection is warranted. Several questions deserve consideration before committing to a luxury skincare investment:
Who was tested? If a brand's clinical efficacy data does not specify the Fitzpatrick range of its trial participants, the results may not be applicable to your skin. Brands that publish inclusive efficacy data are signaling a higher standard of scientific rigor.
What does the ingredient list reveal? High concentrations of glycolic acid, certain retinoids, and aggressive exfoliants warrant caution for melanin-rich complexions. Ingredients such as tranexamic acid, kojic acid, niacinamide, and azelaic acid have stronger safety and efficacy profiles across a broader range of skin tones.
Is radiance being defined for your skin? Marketing imagery and before-and-after photography remain the most telling indicators of a brand's true frame of reference. If the visual language of radiance does not include your complexion, the formula likely does not, either.
The Obligation of Luxury
The premium price point of luxury skincare carries an implicit promise: that what is offered represents the best available science, applied with the highest degree of care. For that promise to be credible across the full diversity of the American consumer base, it must be grounded in formulation and testing practices that reflect that diversity.
Radiance, at its most refined, is not a single optical effect. It is the visible result of skin functioning at its optimal capacity—and that capacity is equally present in every complexion. The luxury brands that will define the next era of prestige beauty are those willing to invest in the science that proves it.